It’s astonishing that Mr. Eby would be so ignorant of the broad authority held within a bill for which he’s responsible. Such ...
An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...